Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Second Quarter ended June 30, 2016
Filing Date: August 2, 2016
This filing serves as a cover document announcing the release of the Company's second-quarter 2016 results via an Investor News release. The actual financial data is contained in attached Exhibits 99.1 and 99.2, which are not included in the text of this filing.
Key Financial Metrics
The text of this Form 6-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references the following metrics as being detailed in the attached exhibits:
- GAAP Measures: Consolidated financial results in accordance with U.S. GAAP.
- Non-GAAP Measures: EBITDA (operating income excluding interest, taxes, depreciation, and amortization) and Free Cash Flow.
Note: Specific figures for these metrics are not present in the provided source text.
Material Changes
The filing text does not disclose specific material changes, percentage growth, or declines compared to prior periods. It states that the attached Investor News contains the comparative financial results.
Guidance, Outlook, and Risks
Management Commentary: Management states that non-GAAP measures (EBITDA and Free Cash Flow) are provided to enhance understanding of current performance and future prospects, and to ensure consistency with historical reporting.
Regulatory Note: The filing explicitly states that the attached exhibits shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and are not subject to the liabilities of that section.
Risks and Contingencies: No specific risks or contingencies are detailed in this cover document.
Investor Verification Checklist
- Verify the specific Q2 2016 revenue and net income figures in Exhibit 99.1 (Investor News).
- Review the reconciliation of non-GAAP measures (EBITDA and Free Cash Flow) to GAAP measures in Exhibit 99.1.
- Confirm the exact debt levels and liquidity position in the financial statements referenced in Exhibit 99.2.
- Check for any forward-looking guidance or updated full-year outlook in the attached Investor News.